Synlett 2014; 25(18): 2654-2660
DOI: 10.1055/s-0034-1379182
letter
© Georg Thieme Verlag Stuttgart · New York

Diastereoselective Synthesis of Methanopyridoxazocinones

Oleksandr S. Detistov
a   Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, FL 32611-7200, USA
,
Siva S. Panda*
a   Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, FL 32611-7200, USA
,
Peter J. Steel
b   Chemistry Department, University of Canterbury, Christchurch 8140, New Zealand
,
Abdullah M. Asiri
c   Chemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
d   Center of Excellence for Advanced Material Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia   Fax: +1(352)3929199   Email: sspanda12@gmail.com   Email: charlesdennishall@gmail.com
,
C. Dennis Hall*
a   Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, FL 32611-7200, USA
,
Alan R. Katritzky ,†
a   Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, FL 32611-7200, USA
c   Chemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
› Author Affiliations
Further Information

Publication History

Received: 12 June 2014

Accepted after revision: 29 August 2014

Publication Date:
07 October 2014 (online)


Abstract

Two approaches to the synthesis of oxygen-bridged tetrahydropyridones have been developed. In the first approach, substituted pyrido[4,3-g][1,3]oxazocines derivatives were prepared by diastereoselective one-pot reactions of substituted 7-azacoumarins with enolizable ketones and non-bulky primary amines. In the second one, 3-amido-7-azacoumarins were reacted with enolizable ketones in the presence of a base to form diastereomerically pure pyrido[4,3-g][1,3]oxazocines.

Supporting Information

 
  • References

  • 1 Lipinski C, Hopkins A. Nature (London) 2004; 432: 855
  • 2 Schreiber SL. Science 2000; 287: 1964
  • 3 Dua R, Shrivastava S, Sonawane SK, Srivastava SK. Adv. Biol. Res. 2011; 5: 120
  • 4 Murray DH, Mendes J, Brown SA. The Natural Coumarins: Occurrence, Chemistry and Biochemistry . Wiley; New York: 1982: 45-46
  • 5 Kulkarni MV, Kulkarni GM, Lin CH, Sun CM. Curr. Med. Chem. 2006; 13: 2795
  • 6 Egan D, O’Kennedy R, Moran E, Cox D, Prosser E, Thornes RD. Drug Metab. Rev. 1990; 22: 503
  • 7 Hoult JR. S, Paya M. Gen. Pharmacol. 1996; 27: 713
  • 8 Lacy A, O’Kennedy R. Curr. Pharm. Des. 2004; 10: 3797
  • 9 Kostova I. Curr. HIV Res. 2006; 4: 347
  • 10 Hadjipavlou-Litina D, Kontogiorgis C, Pontiki E, Dakanali M, Akoumianaki A, Katerinopoulos HE. J. Enzyme Inhib. Med. Chem. 2007; 22: 287
  • 11 Armstrong WR, Combs AP, Tempest PA, Brown SD, Keating TA. Acc. Chem. Res. 1996; 29: 123
  • 12 Boehm T. Arch. Pharm. 1934; 272: 406
  • 13 Koelsch CF, Freerks MC. J. Org. Chem. 1953; 18: 1538
  • 14 Sammour A, Alkady M. Indian J. Chem. 1974; 12: 51
  • 15 Hassan MA, Mohamed MM, Soliman EA, Elwy AM. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1979; 18: 460
  • 16 Koelsch CF, Embree HD. J. Org. Chem. 1958; 23: 1606
  • 17 El-Garby Younes M, El-Kady M, Essawy AI, Mohamed AY. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1981; 20: 747
  • 18 Selim MR, Emam HA, Radwan AM, Sayde AZ. Proc. Indian Natn. Sci. Acad., Sect. A 1996; 62: 429
  • 19 El-Kady M, El-Hashash MA, Sayed MA, El-Sherif M. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1981; 20: 491
  • 20 Deredas D, Albrecht L, Maniukiewicz W. RSC Adv. 2013; 3: 6821
  • 21 Billeret D, Blondeau D, Sliwa H. J. Heterocycl. Chem. 1993; 30: 671
  • 22 Trecourt F, Marsais F, Gungor T, Queguiner G. J. Chem. Soc., Perkin Trans. 1 1990; 2409
  • 23 Yavari I, Adib M, Hojabri L. Tetrahedron 2002; 58: 6895
  • 24 Zhuravel IO, Kovalenko SM, Zaremba OV, Detistov OS, Kovalenko SS, Chernykh VP. Synth. Commun. 2008; 38: 3778